AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) Stock Short Interest Report for October

AXIM Biotechnologies, Inc. (OTCMKTS:AXIM) saw a significant growth in short interest in the month of October. As of October 15th, there was short interest totaling 191,030 shares, a growth of 131.3% from the September 30th total of 82,602 shares. Based on an average trading volume of 265,774 shares, the short-interest ratio is currently 0.7 days.

AXIM Biotechnologies Stock Performance

Shares of AXIM stock remained flat at $0.00 during mid-day trading on Friday. The company’s stock had a trading volume of 34,946 shares, compared to its average volume of 269,237. AXIM Biotechnologies has a 12 month low of $0.00 and a 12 month high of $0.03.

About AXIM Biotechnologies

AXIM Biotechnologies, Inc is a biotechnology company focused on developing diagnostic technologies and related healthcare products. Its activities have included research into rapid immunoassay platforms designed to detect biological markers in areas such as infectious disease and oral health.

During the COVID-19 pandemic, AXIM worked on diagnostic products intended to identify SARS-CoV-2 infection and neutralizing antibodies. The company has also explored applications for its testing technologies in oral-care and other clinical settings, although product availability and regulatory status may vary by product and jurisdiction.

AXIM’s business has primarily centered on research, product development, and potential commercialization through regulatory and strategic partnerships.